WCM Investment Management LLC Increases Holdings in Surgery Partners, Inc. (NASDAQ:SGRY)

WCM Investment Management LLC raised its stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 0.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 522,084 shares of the company’s stock after buying an additional 1,819 shares during the period. WCM Investment Management LLC’s holdings in Surgery Partners were worth $16,665,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. First Eagle Investment Management LLC raised its stake in Surgery Partners by 16.5% during the 1st quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock valued at $10,127,000 after buying an additional 48,100 shares during the last quarter. Bamco Inc. NY raised its stake in Surgery Partners by 100.0% during the 1st quarter. Bamco Inc. NY now owns 90,000 shares of the company’s stock valued at $2,685,000 after buying an additional 45,000 shares during the last quarter. Lombard Odier Asset Management Europe Ltd purchased a new stake in Surgery Partners during the 2nd quarter valued at $4,163,000. Rhumbline Advisers increased its stake in shares of Surgery Partners by 19.6% in the 2nd quarter. Rhumbline Advisers now owns 127,952 shares of the company’s stock worth $3,044,000 after purchasing an additional 20,963 shares in the last quarter. Finally, Janus Henderson Group PLC increased its stake in shares of Surgery Partners by 7,987.1% in the 1st quarter. Janus Henderson Group PLC now owns 2,504,248 shares of the company’s stock worth $74,701,000 after purchasing an additional 2,473,282 shares in the last quarter.

Analysts Set New Price Targets

Several equities research analysts have recently commented on SGRY shares. Benchmark restated a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. Royal Bank of Canada restated an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a research note on Wednesday, August 7th. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Macquarie restated an “outperform” rating and issued a $35.00 price objective on shares of Surgery Partners in a research note on Monday, November 4th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research note on Friday, October 4th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $40.13.

Surgery Partners Stock Up 3.5 %

SGRY opened at $31.43 on Tuesday. The firm has a 50-day simple moving average of $31.04 and a two-hundred day simple moving average of $28.41. Surgery Partners, Inc. has a 52 week low of $22.25 and a 52 week high of $36.92. The company has a market capitalization of $4.00 billion, a PE ratio of -116.40, a price-to-earnings-growth ratio of 2.36 and a beta of 2.76. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.